AAAAAA

   
Results: 1-10 |
Results: 10
Heteroresistance to vancomycin in Enterococcus faecium
Authors: Alam, MR Donabedian, S Brown, W Gordon, J Chow, JW Zervos, MJ Hershberger, E
Citation: Mr. Alam et al., Heteroresistance to vancomycin in Enterococcus faecium, J CLIN MICR, 39(9), 2001, pp. 3379-3381
Pharmacokinetics and pharmacodynamics of ceftizoxime in patients with dosages adjusted for renal function
Authors: Neuhauser, MM McKinnon, PS Hershberger, E Rybak, MJ
Citation: Mm. Neuhauser et al., Pharmacokinetics and pharmacodynamics of ceftizoxime in patients with dosages adjusted for renal function, PHARMACOTHE, 20(5), 2000, pp. 554-561
PCR fragment length polymorphism analysis of vancomycin-resistant Enterococcus faecium
Authors: Donabedian, S Hershberger, E Thal, LA Chow, JW Clewell, DB Robinson-Dunn, B Zervos, MJ
Citation: S. Donabedian et al., PCR fragment length polymorphism analysis of vancomycin-resistant Enterococcus faecium, J CLIN MICR, 38(8), 2000, pp. 2885-2888
Comparison of a rabbit model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetations
Authors: Hershberger, E Coyle, EA Kaatz, GW Zervos, MJ Rybak, MJ
Citation: E. Hershberger et al., Comparison of a rabbit model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetations, ANTIM AG CH, 44(7), 2000, pp. 1921-1924
Activities of trovafloxacin and ampicillin-sulbactam alone or in combination versus three strains of vancomycin-intermediate Staphylococcus aureus inan in vitro pharmacodynamic infection model
Authors: Aeschlimann, JR Hershberger, E Rybak, MJ
Citation: Jr. Aeschlimann et al., Activities of trovafloxacin and ampicillin-sulbactam alone or in combination versus three strains of vancomycin-intermediate Staphylococcus aureus inan in vitro pharmacodynamic infection model, ANTIM AG CH, 44(5), 2000, pp. 1153-1158
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains
Authors: Rybak, MJ Hershberger, E Moldovan, T Grucz, RG
Citation: Mj. Rybak et al., In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains, ANTIM AG CH, 44(4), 2000, pp. 1062-1066
Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model
Authors: Hershberger, E Rybak, MJ
Citation: E. Hershberger et Mj. Rybak, Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model, ANTIM AG CH, 44(3), 2000, pp. 598-601
Activities of LY333328 and vancomycin administered alone or in combinationwith gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model
Authors: Aeschlimann, JR Allen, GP Hershberger, E Rybak, MJ
Citation: Jr. Aeschlimann et al., Activities of LY333328 and vancomycin administered alone or in combinationwith gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model, ANTIM AG CH, 44(11), 2000, pp. 2991-2998
Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcusaureus
Authors: Aeschlimann, JR Hershberger, E Rybak, MJ
Citation: Jr. Aeschlimann et al., Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcusaureus, ANTIM AG CH, 43(8), 1999, pp. 1914-1918
Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods
Authors: Hershberger, E Aeschlimann, JR Moldovan, T Rybak, MJ
Citation: E. Hershberger et al., Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods, ANTIM AG CH, 43(3), 1999, pp. 717-721
Risultati: 1-10 |